AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
15.9 USD
-0.2 (-1.24%)
15.9 USD
0 (0%)
AMN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. AMN has an average financial health and profitability rating. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AMN's Return On Assets of -12.88% is on the low side compared to the rest of the industry. AMN is outperformed by 77.23% of its industry peers.
The Return On Equity of AMN (-42.76%) is worse than 74.26% of its industry peers.
AMN has a Return On Invested Capital (2.08%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is above the industry average of 9.58%.
The last Return On Invested Capital (2.08%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN's Operating Margin of 1.65% is in line compared to the rest of the industry. AMN outperforms 46.53% of its industry peers.
In the last couple of years the Operating Margin of AMN has declined.
The Gross Margin of AMN (29.37%) is comparable to the rest of the industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
Compared to 1 year ago, AMN has more shares outstanding
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.40 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN's Altman-Z score of 2.40 is in line compared to the rest of the industry. AMN outperforms 52.48% of its industry peers.
AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
The Debt to FCF ratio of AMN (3.80) is better than 72.28% of its industry peers.
A Debt/Equity ratio of 1.31 is on the high side and indicates that AMN has dependencies on debt financing.
AMN has a worse Debt to Equity ratio (1.31) than 67.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.26
WACC7.89%
2.3 Liquidity
AMN has a Current Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN has a Current ratio of 1.05. This is in the lower half of the industry: AMN underperforms 69.31% of its industry peers.
AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN has a Quick ratio of 1.05. This is in the lower half of the industry: AMN underperforms 62.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.29%.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.42%.
Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 6.07% on average per year.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.40% yearly.
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.41, the valuation of AMN can be described as reasonable.
95.05% of the companies in the same industry are more expensive than AMN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.84, AMN is valued rather cheaply.
AMN is valuated rather expensively with a Price/Forward Earnings ratio of 20.59.
60.40% of the companies in the same industry are more expensive than AMN, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AMN to the average of the S&P500 Index (23.40), we can say AMN is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.41 | ||
| Fwd PE | 20.59 |
4.2 Price Multiples
AMN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMN is cheaper than 84.16% of the companies in the same industry.
99.01% of the companies in the same industry are more expensive than AMN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.74 | ||
| EV/EBITDA | 6.87 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -29.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)10.46
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
15.9
-0.2 (-1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.78%
Inst Owner Change0.21%
Ins Owners0.43%
Ins Owner Change2.77%
Market Cap610.72M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target20.84 (31.07%)
Short Float %6.73%
Short Ratio2.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)-2.39%
PT rev (3m)2.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)41.93%
EPS NY rev (1m)20.88%
EPS NY rev (3m)20.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.48%
Revenue NY rev (1m)4.59%
Revenue NY rev (3m)4.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.41 | ||
| Fwd PE | 20.59 | ||
| P/S | 0.22 | ||
| P/FCF | 2.74 | ||
| P/OCF | 2.29 | ||
| P/B | 0.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.87 |
EPS(TTM)1.89
EY11.89%
EPS(NY)0.77
Fwd EY4.86%
FCF(TTM)5.8
FCFY36.48%
OCF(TTM)6.94
OCFY43.67%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)10.46
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.4 |
F-Score4
WACC7.89%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.95%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 4 / 10.